Go to contentGo to menuGo to searchGo to the news list

INSERM UMR 1063 : Stress oxydant et pathologies métaboliques (SOPAM)

Main navigation



    Year 2019

    Year 2019

    • Share this page on social networks
    • E-mail this page

      Send by mail

      Separated by coma
    • Print this page
    • Bousseau S, Marchand M, Soleti R, Vergori L, Hilairet G, Recoquillon S, Le Mao M, Gueguen N, Khiati S, Clarion L, Bakalara N, Martinez MC, Stéphane Germain S, Lenaers G, Andriantsitohaina R; Phostine 3.1a as a pharmacological compound with anti-angiogenic properties against diseases with excess vascularization. Faseb Journal. 2019 (in Press).